Gamma linolenic acid sales will expand through 2035, with conventional gamma linolenic acid at 85.4% of nature sales and liquid form gamma linolenic acid at 69.1% within the form segment in 2025. The market was valued at USD 197.2 million in 2025 and is forecast to record a 4.9% CAGR between 2025 and 2035.